Today, a Director at Simulations Plus (SLP), Walter Woltosz, bought shares of SLP for $251.6K.
Following Walter Woltosz’s last SLP Buy transaction on April 23, 2018, the stock climbed by 1.1%.
See today’s analyst top recommended stocks >>
Based on Simulations Plus’ latest earnings report for the quarter ending August 31, the company posted quarterly revenue of $6.69 million and quarterly net profit of $1.34 million. In comparison, last year the company earned revenue of $6.27 million and had a net profit of $1.15 million. SLP’s market cap is $351.6M and the company has a P/E ratio of 38.20. Currently, Simulations Plus has an average volume of 293.7K.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. Its services include consulting services, modeling and analysis or simulation, pharcometric data assembly, and training and workshops.
